BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6533963)

  • 1. Apheresis is of no value in SLE.
    Hunsicker LG
    Trans Am Soc Artif Intern Organs; 1984; 30():697-9. PubMed ID: 6533963
    [No Abstract]   [Full Text] [Related]  

  • 2. Apheresis is of value in SLE.
    Hebert LA
    Trans Am Soc Artif Intern Organs; 1984; 30():697. PubMed ID: 6533962
    [No Abstract]   [Full Text] [Related]  

  • 3. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial plasmapheresis treatment results in glomerulonephritis].
    Nenov D; Stanchev I; Chankova P
    Vutr Boles; 1981; 20(2):105-8. PubMed ID: 7257329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial management of lupus glomerulonephritis.
    Knutson DW
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):229-36. PubMed ID: 7102672
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis for the treatment of severe lupus nephritis: uncontrolled observations.
    Lewis EJ
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):182-7. PubMed ID: 7102667
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 8. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis in human therapeutics].
    Kennes B
    Rev Med Brux; 1983 Dec; 4(10):649-57. PubMed ID: 6658248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmapheresis in treating circulating immune complex diseases].
    Geavlete A; Viorel D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):377-83. PubMed ID: 2865800
    [No Abstract]   [Full Text] [Related]  

  • 11. Scientific overview of systemic lupus erythematosus (SLE).
    Jasin HE
    Prog Clin Biol Res; 1982; 106():65-80. PubMed ID: 6757954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmapheresis in the treatment of immunological nephropathies].
    Frasca' G; Vangelista A; Nanni Costa A; Cucudis P
    G Clin Med; 1981 Apr; 62(4):260-9. PubMed ID: 7021294
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression.
    Isbister JP; Ralston M; Hayes JM; Wright R
    Arch Intern Med; 1981 Jul; 141(8):1081-3. PubMed ID: 7247596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for the application of plasmapheresis (author's transl)].
    Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ
    MMW Munch Med Wochenschr; 1982 Jul; 124(27):641-5. PubMed ID: 6810157
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic plasmapheresis; present state and future aspects.
    Gurland HJ; Samtleben W; Blumenstein M
    Life Support Syst; 1983; 1(1):61-70. PubMed ID: 6379316
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphoplasmapheresis for acute systemic lupus erythematosis (SLE).
    Gluck O; Dorson WJ
    Trans Am Soc Artif Intern Organs; 1984; 30():678. PubMed ID: 6533954
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmapheresis in hereditary angioneurotic edema and systemic lupus erythematosus.
    Young DW; Thompson RA; Mackie PH
    Arch Intern Med; 1980 Jan; 140(1):127-8. PubMed ID: 7352788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic plasmapheresis. Possible indications].
    Nielsen LP
    Ugeskr Laeger; 1983 Apr; 145(14):1041-7. PubMed ID: 6683438
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.